• Fri frakt över 249 kr
  • •
  • Snabba leveranser
  • •
  • Billiga böcker
Kundservice

Du är på sajten för privatpersoner.

Företag, bibliotek eller offentlig verksamhet?

Du handlar på classic.bokus.com, där alla dina funktioner finns intakta.
Till classic.bokus.com
Bokus logotyp. Gå till startsidan.
  • Erbjudanden
  • Nyheter
  • Student
  • Topplistor
  • Barn & ungdom
  • Bokus Play
  • E-böcker
  • Pocketböcker
  • Spel & pussel

10% rabatt på allt med kod: NYSTART10 →

Sidfot

Mina sidor

    Hjälp

    • Kundservice
    • Vanliga frågor och svar
    • Frakt och leverans
    • Retur vid ångerrätt
    • Reklamera vara
    • Betalning
    • Köpvillkor
    • Allmänna villkor
    • Information om webbplatsens tillgänglighet

    Om Bokus

    • Om oss
    • Pressrum
    • För studenter
    • För företag
    • För bibliotek och offentlig verksamhet
    • För leverantörer
    • Hållbarhet

    Populärt

    • Aktuella erbjudanden
    • Presentkort
    • Studentlitteratur
    • Nya böcker
    • Topplistor
    • Signerade böcker
    • Engelska böcker

    Inspiration

    • Boktips
    • BookTok
    • Populära bokserier
    • Barnbokskaraktärer
    • Populära författare
    Logotyp för Bokus
    Följ oss på Facebook (extern länk)Följ oss på Instagram (extern länk)Följ oss på YouTube (extern länk)Följ oss på TikTok (extern länk)
    bokus @ CookiesAnpassa cookiesIntegritetspolicyKöpvillkor
    Till Citymail hemsida (extern länk)Till Budbee hemsida (extern länk)Till Postnord hemsida (extern länk)Till Schenker hemsida (extern länk)Till Early Bird hemsida (extern länk)Till Walleys hemsida (extern länk)
    1. Medicin
    2. Medicin: allmänt

    Treating Individuals

    From randomised trials to personalised medicine

    AvPeter M. Rothwell

    Häftad, Engelska, 2007

    583 kr

    Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

    Beskrivning

    Inspired by a hugely successful series entitled Treating Individuals, originally published in The Lancet, this volume will become essential reading for any professional involved with performance and evaluation of trials and systematic reviews or clinical patient care. There are many books explaining the importance of evidence-based medicine and how randomised clinical trials (RCTs) and systematic reviews should be performed. However, this is the first book to tackle the apparent conflict between the importance of evidence-based decision making and the widely held view that it is often very difficult to apply the overall results of RCTs and systematic reviews to decisions about individual patients in routine clinical practice. The book brings together experienced clinicians, statisticians and trialists to focus on the two key questions that are most frequently asked by clinicians. Is the evidence relevant to my clinical practice? How can I judge whether the probability of benefit from treatment in my current patient is likely to differ substantially from the average probability of benefit reported in the relevant trial or systematic review? These questions are addressed from methodological and clinical perspectives, and potential approaches to improving the targeting of treatment are considered, with detailed reviews of several areas of medicine and surgery where useful progress has been made.

    Produktinformation

    • Utgivningsdatum:2007-07-02
    • Mått:156 x 234 x undefined mm
    • Vikt:640 g
    • Format:Häftad
    • Språk:Engelska
    • Förlag:Elsevier Science & Technology
    • ISBN:9780080447391

    Utforska kategorier

    • Medicin: allmänt inom Medicin

    Innehållsförteckning

    • Section 1: Reliable determination of the overall effects of treatments1) Reliable assessment of the effects of treatment on mortality and major morbidity2) The lethal consequences of failing to make full use of all relevant evidence about the effects of medical treatments: the importance of systematic reviewsSection 2: Is the trial relevant to this patient?3) Assessment of the external validity of randomised trials 4) Applying results to treatment decisions in primary care5) The older patient6) Applying results to treatment decisions in complex clinical situations7) External validity of pharmaceutical trials in neuropathic pain8) External validity of pharmaceutical trials in asthma and chronic obstructive pulmonary diseaseSection 3: Is the overall trial result sufficiently relevant this patient?9) When should we expect clinically important differences in response to treatment?10) Genes and the individual response to treatment11) Reliable estimation and interpretation of the effects of treatment in subgroups12) Can meta-analysis help target interventions at individuals most likely to benefit?13) Use of risk models to predict the likely effects of treatment in individuals14) Evaluating the performance of prognostic models15) Are "n-of-1” trials of any practical value to clinicians or researchers?Section 4: Targeting of treatment in routine practice16) Primary prevention of cardiovascular disease: the absolute risk-based approach17) Antithrombotic therapy to prevent stroke in patients with atrial fibrillation18) Reperfusion therapies in acute cardiovascular and cerebrovascular syndromes19) Choice of agent in treatment of epilepsy20) Pharmacogenomic targeting of treatment for cancer